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Mechanisms of hypoalbuminemia in hemodialysis patients. Hypoalbu-
minemia is the most powerful predictor of mortality in end-stage renal
disease. Since protein-calorie malnutrition can decrease albumin synthesis
it is assumed that hypoalbuminemia results principally from malnutrition
in these patients, but albumin synthesis may also be decreased as part of
the acute-phase response, and hypoalbuminemia can also result from
redistribution of albumin pools or from albumin losses. We measured
albumin synthesis, fractional catabolic rate, and distribution from the
turnover of [125!] human albumin in six hemodialysis patients with plasma
albumin less than 35 mg/mI and in six patients with plasma albumin
greater than 40 mg/mI. Patients with liver disease, HIV, or other infection
were excluded. Both groups were maintained with high-flux polysulfone
dialyzers for more than three months. Kt/Vurea and PCR were measured
during each dialysis (N = 12 to 18/patient). A four-day calorie and protein
intake was determined by dietary history and long-term nutritional status
was determined anthropometrically. Measured variables included serum
urea, creatinine, transferrin, and the positive acute-phase proteins a2-
macroglobulin, C-reactive protein, ferritin, and !GF-1. Albumin synthesis
was significantly reduced in the low albumin group. There were no
differences in dietary intake, body composition, PCR, BUN, creatinine, or
Kt/Vurea. Plasma albumin concentration correlated negatively with fer-
ritin, C-reactive protein and a2-macroglobulin. Albumin synthesis rate
correlated negatively with both a2-macroglobulin and Kt/Vuyea. Both
plasma albumin concentration and synthesis rate correlated positively with
!GF-1, and both were independent of PCR and all other nutrition-related
variables. Hypoalbuminemia was due to decreased albumin synthesis. The
data suggest that albumin concentration and synthesis were primarily
determined by non-nutritional factors in this well-dialyzed population, and
that both were reduced partially as part of the acute-phase response.
Hypoalbuminemia is the most powerful predictor of death in
patients with end-stage renal disease (ESRD), yet the cause of
hypoalbuminemia in the ESRD patient population is unknown
[1]. During steady-state conditions, the concentration of any
protein in plasma is determined by its rate of synthesis and
catabolism, by external losses, and by its distribution in the body.
Experimental models of renal failure in rats [2, 3] as well as
studies in dialysis patients [4] have shown that renal failure per se
does not suppress albumin synthesis nor lead to reduced albumin
pools. Indeed, the majority of patients on maintenance hemodi-
alysis have normal albumin concentrations [1]. The collective data
suggest that hypoalbuminemia is not a consequence of renal
failure but instead must result from a separate process.
One of the most powerful regulators of albumin synthesis is
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availability of dietary protein [5—7]. Protein malnutrition de-
creases albumin synthesis [8] at the level of RNA transcription [7,
8] and by post-transcriptional mechanisms [9]. Protein calorie
malnutrition is clearly a potential cause of reduced albumin
synthesis, decreased plasma albumin levels, and increased mor-
bidity and mortality in the chronically ill population, and malnu-
trition has been documented in the ESRD population [10—12]. It
has been generally assumed that hypoalbuminemia in this popu-
lation is purely nutritionally based. Indeed, the term hypoalbu-
minemia and malnutrition are often used synonymously in refer-
ence to these patients.
Were protein malnutrition the only cause of hypoalbuminiemia
in the dialysis patient population, one would expect to find a
correlation between hypoalbuminemia and the rate of urea gen-
eration, as a reflection of net protein catabolism, and nutritional
supplementation should effectively restore albumin pools as it
does in patients with hypoalbuminemia caused by protein malnu-
trition [5, 13]. Such associations have not been easily identifiable
[14, 15].
In addition to being nutritionally modulated, albumin is also a
negative acute-phase reactive protein [16]. During an inflamma-
tory reaction the plasma concentration of positive acute-phase
reactive proteins such as C-reactive protein, a1-acid glycoprotein,
and a2-macroglobulin is increased, while albumin concentration is
reduced even in the absence of malnutrition [17—19]. Plasma cr2
macroglobulin functions as a carrier for IL-6 in humans [20, 21],
increases during hemodialysis with cuprophane dialyzers [22], and
increases following acute myocardial infarction [23]. Thyroid
hormone, growth hormone and cortisol are also required for
maintenance of a basal rate of albumin synthesis [5]. Thus if
hypoalbuminemia in ESRD patients is a consequence of a re-
duced rate of albumin synthesis, reduced albumin synthesis could
be a consequence of protein malnutrition, inflammation, hormone
deficiency states, or a combination of these processes.
It is also possible for hypoalbuminemia to occur without a
decrease in the rate of albumin synthesis. Hypoalbuminemia may
reflect pathologic redistribution of albumin from the vascular
compartment to the extravascular space, such as occurs following
trauma or during sepsis [24, 25]. We found that plasma albumin
concentrations were reduced in rats with chronic renal failure in
part as a result of plasma volume expansion, with little or no
reduction in either plasma or total albumin mass or in albumin
synthesis f2J.
Increased extracorporeal losses as in the nephrotic syndrome
can also cause hypoalbuminemia [7, 26]. Albumin synthesis is
usually increased under these circumstances [7, 27, 28]. It is
510
Kaysen et a!: Hypoalbuminemia in hemodialysis 511
possible that some albumin might be lost across the dialysis
membrane in patients on hemodialysis, contributing to hypoalbu-
minemia in them [29], and some may have significant residual
proteinuria. These losses can be quantified.
Methods
We measured albumin turnover and distribution in a group of
ESRD patients maintained on chronic hemodialysis who had low
plasma albumin concentrations compared to another hemodia-
lyzed group whose plasma albumin was normal. Nutritional
parameters and delivery of dialysis were monitored and plasma
levels of specific acute-phase reactive proteins, thyroid hormone,
cortisol, and insulin-like growth factor 1 (IGF-1) and its binding
proteins IGF-1 BP2 and IGF-1 BP3 were measured.
Patients
The protocol was reviewed and approved by the University of
California Davis institutional review board for human studies and
by the radiation safety committee. Patients were recruited from
the University Dialysis Clinic in Sacramento. All patients had
received maintenance hemodialysis for at least three months prior
to entry into the study. Serum albumin concentration was mea-
sured monthly in all patients (N = 120), and those with three
consecutive albumin concentrations below 35 mg/ml were asked
to participate in the study provided they had no clinical evidence
of liver disease, infectious disease, or inflammatory conditions. A
similar group with albumin greater than 40 mg/mi served as
controls.
All patients were maintained with their usual hemodialysis
prescription consisting of high-flux polysulfone hollow fiber dia-
lyzers (model F-80, Fresenius USA, Walnut Creek, CA, USA)
for two to four hours three times per week. Dialysate samples
were taken at 30 minutes, at mid dialysis, and at the end of each
dialysis for albumin measurements. Urine was collected for
measurement of albumin and urea clearance at the midpoint of
the study.
Albumin kinetics
A single 10 pCi dose of [125!] human albumin (Mallinkrodt,
Inc., St. Louis, MO, USA) was injected per patient on a non-
dialysis day into a peripheral vein and 3 ml blood samples were
obtained from a vein in the contralateral arm at 5, 15, 30, 60, 120
minutes, at 5, 24, and 48 hours, and immediately prior to and
following each hemodialysis treatment until plasma I levels
decreased to 10% of original counts (25 to 38 days). Three 400-j.d
plasma aliquots were then counted in a gamma counter (Searle
Analytics, Des Plaines, IL, USA) for 10 minutes as follows.
The samples were counted first directly and then following
protein precipitation with 10% trichloroacetic acid (TCA) and
dissolution of the pellet in 1 N NaOH to remove non-protein
bound 125J, All measurements were carried out in duplicate. In
most cases TCA precipitable and non-TCA precipitable counts
were identical.
The plasma radioactivity disappearance curve was integrated
by the method of trapezoids using the log trapezoidal rule
[30—32]. Plasma albumin mass (PAM), total albumin mass
(TAM), volume of distribution, and albumin turnover were
calculated as previously described [4, 331. The dose injected (D)
divided by the area under the plasma radioactivity curve (AUC)
yields a clearance term (in vol/unit of time). The product of the
clearance term (D/AUC) and plasma albumin concentration [alb]
is total albumin turnover per unit of time. If [alb] does not vary
with time, then:
Total albumin turnover = (D/AUC)[alb] (1)
During preliminary studies we found that serum albumin
concentrations were relatively constant and showed no trend for
three months up to the time of injection (T0), compatible with a
steady state for albumin homeostasis. Plasma albumin concentra-
tion also did not vary significantly for individual patients from day
to day during the study if predialysis values were compared to
predialysis values or postdialysis values were compared to postdi-
alysis values. However, postdialysis concentrations were signifi-
cantly higher than predialysis concentrations, most likely due to
hemoconcentration. Despite a substantial increase in concentra-
tion during dialysis in some patients, the specific radioactivity of
albumin did not change during dialysis.
To avoid potential errors due to changes in albumin concen-
tration in equation 1, specific radioactivity (dpm/mg albumin)
rather than absolute counts were used to measure albumin
turnover. Specific radioactivity contains an albumin concentration
term at each time point in the numerator, so the assumption that
plasma albumin concentration does not vary with time need not
be made. Instead of obtaining a clearance term, the integration of
specific radioactivity at each time point yielded a catabolic rate in
mg/hr directly [4]:
D
Total albumin turnover =
f SA dt
where D is the total dose (dpm) injected at TO and SA is the
trichioroacetic acid precipitable specific radioactivity measured at
each time point (t) in dpm/mg plasma albumin.
Plasma volume was calculated by isotope dilution. Plasma
albumin mass (PAM) is the product of plasma albumin concen-
tration and plasma volume.
Formerly, we had calculated total albumin mass (TAM) from
the steady-state volume of albumin distribution (VDSS) measured
by the method of Benet and Galeazzi [31]:
VD, — (D)(AUMC)I(AUC)2 (3)
We modified this relationship to take into account the changes in
plasma albumin concentration that occur as a consequence of
dialysis. We calculate total albumin mass directly, without calcu-
lating its volume of distribution first:
SA t dt
JoTAM = D
2
(fSA.dt)
where t is time since injection in hours, and SA is the trichioro-
acetic acid precipitable specific radioactivity of plasma albumin in
(2)
(4)
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dpm/mg of albumin. Since a concentration term is included at
each time point integrated, this relationship yields a mass term
rather than a volume term. Integration was done by the method of
trapezoids using the logarithmic rule as previously described [4, 6,
7}, The distribution of albumin between the vascular and extravas-
cular compartments was calculated as the ratio of PAM/TAM.
Albumin catabolic rate was calculated as the difference between
albumin turnover (synthesis) from equation 2 and measured
extracorporeal losses (urinary and dialysis) per hour. Albumin
fractional disappearance rate is defined as the fraction of the
plasma albumin pool that is removed per hour and is 100 (albumin
catabolism hr 1)/PAM.
Measurement of proteins
Albumin (Sigma Chemical Co., St. Louis, MO, USA) was
measured in serum or plasma by bromcresol green binding [34]
and in dialysate and urine by electroimmunodiffusion as described
previously [6]. We first verified that both methods gave the same
result when used for measurement of albumin in serum from the
first six patients studied (3 in each group). a1-Acid glycoprotein
and a2-macroglobulin were also assayed by electroimmunodiffu-
sion; a1-acid glycoprotein and antibodies to a1-acid glycoprotein
were obtained from Accurate Chemical & Scientific Corp. (West-
bury, NY, USA); a2-macroglobulin and antibodies to a2-macro-
globulin were obtained from Organon Teknika Corp (West
Chester, PA, USA). Human albumin and antibodies to human
albumin were obtained from Sigma Chemical Co.
Blood was obtained fasting in the morning prior to dialysis for
measurement of growth hormone, insulin-like growth factor 1
(IGF-1), IGF binding proteins 2 and 3 (IGF-1 BP2 and IGF-1
BP3), cortisol, thyroid stimulating hormone, and thyroxine (T4).
IGF-1 and the two IGF-1 binding proteins were measured by
ELISA (Endocrine Sciences, Calabasas Hills, CA, USA).
Dialysis urea kinetics
Dialyzer blood flows ranged from 230 to 500 ml/min; dialysate
flows were 500 to 800 mI/mm in the opposite direction. Single- and
two-pool models of urea kinetics were used to calculate the
normalized protein catabolic rate (PCRn) and the delivered dose
of dialysis (Kt/Vurea) as previously described [351.
Nutritionaldetenninations
Patient weights were measured after each dialysis. Food records
were analyzed for four days at the midpoint of the kinetic study
for protein and calorie intake. Height was measured and anthro-
pometric measurements of biceps, triceps, subscapular and su-
prailiac skinfold thickness were taken using a Lange skinfold
caliper. Measurements were made at least four times by the same
observer and the mean value was used for each calculation.
Midarm muscle circumference was determined from the triceps
skinfold thickness and midarm circumference [36].
Dialyzer reuse
Dialyzers were reprocessed using an automated computer-
controlled reuse system (Seratronics DRS4, Fresenius USA) that
cleans the dialyzer with bleach and sterilizes with 1.5% formalin.
Dialyzers were discarded if fiber bundle volume fell below 80% of
the original (first use) volume.
Statistical methods
We prospectively examined both albumin synthesis and average
plasma albumin concentration as they related to five nutritional
parameters, three acute-phase proteins, and four dialysis-related
variables. The nutritional parameters were dietary protein intake
and dietary calorie intake by dietary history, % body fat, arm
muscle circumference, and plasma transferrin level. The acute-
phase proteins were a2-macroglobulin, a1-acid glycoprotein, fer-
ritin, and C reactive protein. The variables related to dialysis were
Kt/Vurea, PCRn, BUN, and serum creatinine concentrations.
Multiple regression analysis was performed using multiple step-
wise addition of variables and an F value of 3 as a minimum for
including a variable in the analysis. Differences between groups
were analyzed using a one way analysis of variance with post-hoc
Student-Newman-Keuls comparison [37]. P values less than 0.05
were considered statistically significant.
Results
Albumin synthesis was significantly greater in patients with
normal albumin levels compared to those with reduced plasma
albumin (Table 1). Albumin fractional catabolic rate tended to be
reduced in the low albumin group, but the differences did not
achieve statistical significance, and the decrease in catabolism was
clearly not sufficient to maintain a normal plasma albumin con-
centration. Plasma volume and the distribution of albumin be-
tween the plasma and extraplasma space was also not different
between the two groups. The presence or absence of diabetes had
no effect on albumin synthesis. Albumin synthesis in the hypoalbu-
minemic diabetic group was 11.20 1.42 g/1.73 m2/day compared
to 11.95 0.29 g/1.73 m2/day in the non-diabetic hypoalbumin-
emic group, and was 14.98 4.07 g/1.73 m2/day in the diabetic
normal albumin group compared to 14.58 1.88 g/1.73 m2/day in
the non-diabetic normal albumin group. Acidosis, a recently
recognized cause of decreased albumin synthesis [38], was not a
factor as is evident from the normal pre-dialysis serum bicarbon-
ate concentrations throughout the study (Table 1).
The most significant extracorporeal loss of albumin occurred
during dialysis. Losses of albumin in the dialysate, while not
different between the groups statistically, tended to be greater in
the hypoalbuminemic patients (1.03 0.91 g/1.73 m2/day vs. 0.48
0.35 g/1.73 m2/day) and was related to reuse number (Fig. 1).
Only one patient had significant urinary albumin loss (Patient #5
to 2.18 g/day); this patient was also in the low albumin group.
There was no evidence of either hypocortisolism or of hypothy-
roidism in either group (Table 1). The most striking endocrino-
logic finding was a difference in plasma IGF-1 levels, which was
significant and almost threefold in magnitude. With the exception
of patient #11 there was no overlap between the groups. This
patient also had a greatly elevated growth hormone level (39.7
ng/ml), and was entirely responsible for the increased mean
growth hormone level in the normal albumin group. The differ-
ence in IGF-1 levels was not a consequence of altered binding
proteins levels, since the plasma levels of IGF-1 BP2, and IGF-1
BP3 were not different, although IGF-1 BP2 was significantly
increased in both groups.
There were no differences in body wt, in percent total body fat,
or in arm muscle circumference, although the high albumin group
tended to have slightly greater muscle mass and the patients with
low albumin tended to have more fat (Table 1). Dietary protein
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Table 1. Nutritional and related characteristics of hemodialysis patients
with low and normal serum albumin concentrations
Low Normal
albumin albumin
Albumin
Plasma concentration at T0 mg/mi
Mean plasma concentration mg/mi
Synthesis rate gIl. 73 m2/day
Losses
Dialysate gIl. 73 m2/dialysis
Urine g/173 m2/day
Fractional disappearance % plasma
pool/hr
Catabolic rate gIl. 73 m2/day
Fractional catabolic rate % plasma
pool/hr
PAM/TAM
Plasma volume % body wt
Values are means SD. Serum concentrations are predialysis values;
dietary protein and calorie intakes are the mean of 4 days; PCRn is the
normalized protein catabolic rate and is the mean of 12 to 18 measurementsl
patient; Kt/V,rea is the amount of dialysis delivered to the patient per
treatment; PAMJTAM is the ratio of plasma albumin mass to total albumin
mass; IGF-1 is insulin-like growth factor 1; BP is binding protein.
P < 0.05 vs. the low albumin group
0
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01020 30 40 50 60
Reuse number
Fig. 1. Albumin losses across the dialyzer during individual dialysis sessions
compared to the number of times the dialyzer had been used. Symbols are:
(•) normal albumin group; (0) low albumin group.
Table 2. Partial regression coefficients for factors detennining
parameters of albumin synthesis and plasma albumin concentration in
patients on hemodialysis
Variable Regression Partial r2 Probability F
Albumin synthesis
a2-macroglobulin —1.6331 0.3854 0.04154 5.643
Kt/Vurea —2.8474 0.2921 0.08606 3.714
Plasma albumin
concentrationa
Ferritin —3.8328 0.6669 0.00394 16.016
a2-macroglobulin —0.0178 0.5936 0.00911 11.683
C-reactive protein —2.6002 0.5149 0.01946 8.493
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Patients
Male/female
Age years
Age range years
Diabetic/non-diabetic
Height cm
Weight kg
Surface area m2
Fat % body weight
Arm muscle circumference cm
Dialysis & nutrition
Months on dialysis
Average reuse number
BUN mg/dl
Creatinine mg/dl
HCO3 mmol/liter
Total protein gi/dI
Cholesterol mg/dl
Triglycerides mg/di
Hematocrit %
Transferrin mg/dl
Dietary protein intake g/kg/day
Dietary calorie intake kCai/kg/day
PCRn g/kg/day from urea kinetics
Kt/Vara /dialysis from urea kinetics
6
4
2
0
0
.
0
0
00
0
• 00
0
00 000 00 000
-
4/2
67.7 12.6
45—88
4/2
166 15
70.6 13.3
1.78 0.26
24.9 14.3
23.7 3.2
35.2 22.2
19.5 17.8
60.5 20.6
8.9 3.6
25.8 1.8
7.05 0.42
179 23.4
174 72.1
29.3 3.9
260 31.7
1.03 0.40
28.1 9.1
1.04 0.211
1.55 0.49
32.3 4.6
32.3 4.3
11.30 1.10
1.03 0.91
0.38 0.88
0.435 0.064
5/1
44.5 15.4
29—74
2/4
170 11
76.3 18.7
1.87 0.15
20.3 8.5
27.2 6.1
44.2 41.3
12.6 3.6
60.2 10.5
12.0 3.2
23.4 1.4
6.97 0.30
188 31
211 142
31.7 1.4
268 32.2
1.06 0.39
29.5 14.4
1.01 0.21
1.27 0.14
40.7 isa
41.9 2.6a
14.70 2.34a
0.48 0.35
0.01 0.02
0.528 0.165
9.99 0.89 14.22 2.19a a Regression analysis was performed using multiple stepwise addition of
0.379 0.027 0.5 11 0.160 variables. Variables were included in the analysis only if F  3. r2 =
0.5944, adjusted r2 = 0.5042 for variables in the multiple regression for
0.413 0.057 0.433 0.078 albumin synthesis rate. Multiple r for included variables = 0.7710, P =
4.40 1.20 4.94 1.09 0.0172 for determinants of albumin synthesis; r2 = 0.8428, adjusted r2 =
0.8857 for determininants of albumin concentration. Multiple r for
included variables = 0.9411, P = 4.007 X iO for determinants of plasma
albumin concentration.
Acute phase reactants
a2-macroglobulin mg/dl
a1-acid glycoprotein mg/di
C-reactive protein mg/dl
Ferritin mg/dl
WBC X103/mm3
Plasma hormones and binding proteins
L-thyroxine jig/dl
Triiodothronine resin uptake %
Thyroid stimulating hormone csU/mi
Cortisol pg/dl
Growth hormone ng/ml
IGF-1 ng/ml
IGF-1 BP3 pg/mi
IGF-1 BP2 ng/ml
4.66 0.51
1.38 0.16
1.23 1.17
194 193
7.15 1.85
5.64 2.24
22.5 3.7
2.2 1.4
14.8 3.9
2.22 1.6
85.3 52.7
3.12 1.31
2546 789
3.37 0.35a
1.28 0.38
0.68 0.20
78.5 66.8a
6.72 2.44
6.05 1.36
23.1 2.1
1.60 1.35
11.7 4.3
7.51 15.78
185.3 61.8a
4.3 0.73
1939 1536
(data not shown), and PCRn was similar to dietary protein intake
estimated from dietary records. Kt/Vurea tended to be greater and
urea distribution volume was smaller in the hypoalbuminemic
patients (Table 1). There was no difference in dialysis time or Kd.
Thus variance in KT/Vurea was entirely a result of the difference in
Vurea. Plasma triglyceride, cholesterol, and transferrin levels were
not different; however the acute-phase reactant proteins a2-
macroglobulin and ferritin were significantly greater and C-reac-
tive protein tended to be greater in the low albumin group (Table
1). Not all acute-phase reactive proteins were increased, however,
as plasma a1-acid glycoprotein was the same in both groups.
By multiple regression analysis, the rate of albumin synthesis
was negatively correlated with cs2-macroglobulin and Kt/Vurea
(Table 2). Albumin synthesis also correlated negatively with
a2-macroglobulin by univariant analysis (Fig. 2).
The initial albumin concentration and the average albumin
concentration did not vary over the entire period of study (Table
1). Average plasma albumin correlated negatively with the posi-
tive acute-phase proteins, a2-macroglobulin, C-reactive protein,
intake and calorie intake were also similar. There were no
differences in BUN or PCRn measured either using the single-
compartment model (Table 1) or the two-compartment model
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The principal cause of reduced plasma albumin concentration
in the low albumin group was a reduced rate of albumin synthesis.
Altered distribution of albumin between the intravascular and
extravascular space was not responsible for hypoalbuminemia in
our patients since the relative distribution between the intravas-
cular and extravascular pools was the same in both groups. While
the albumin fractional catabolic rate was not significantly reduced
in the low albumin group, it tended to be lower, as occurs in many
other hypoalbuminemic conditions such as protein malnutrition
[8, 13], and clearly was not increased, as occurs in the nephrotic
syndrome [27, 30]. Thus the normal homeostatic response of
reduced albumin fractional catabolic rate that occurs when albu-
min concentration is reduced appeared to remain intact.
External albumin losses may have contributed, but cannot be
the primary reason for hypoalbuminemia in the low albumin
group. If external losses were the primary cause of hypoalbumin-
emia the fractional disappearance rate should have been higher,
6 7 but in fact it was reduced in the low albumin group. Furthermore,
the normal response to increased external albumin losses is an
increase in synthesis. This homeostatic response characterizes the
nephrotic syndrome [6, 20] and is not impaired by renal failure.
This has been shown in rats with chronic renal failure where
albumin losses are a consequence of albuminuria [2], and in
patients with ESRD treated with peritoneal dialysis (CAPD) [4].
Rats with CRF increased their rate of albumin synthesis by
approximately 50% [2] and CAPD patients increased albumin
synthesis gram for gram to replace transperitoneal albumin losses
[4]. Thus while albumin losses, either in the urine or across the
dialysis membrane, are undesirable and may contribute to the
reduced albumin levels in the hypoalbuminemic group, the lack of
response to external albumin loss in these patients is further
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u2 macroglobulin, mg/dl
Fig. 2. Relationship between albumin synthesis and plasma cs2-macroglob-
ulin concentration. 95% confidence limits are shown on either side of the
regression line. r =
—0.6534; P = 0.0212.
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Insulin like growth factor-i, ng/ml
Fig. 4. Relationship between albumin synthesis and plasma insulin like
growth factor-i concentration (IGF-i). 95% confidence limits are shown on
either side of the regression line. r =
—0.7131; P = 0.00924.
Discussion
S
20 I I
2 3 4 5
a2 macroglobulin, mg/dl
Fig. 3. Relationship between average plasma albumin concentration and
plasma a2-macroglobulin concentration. 95% confidence limits are shown
on either side of the regression line. r =
—0.704; P = 0.0105.
and ferritin by multiple regression analysis (Table 2). Average
albumin concentration correlated negatively with a2-macroglobu-
un concentration by univariant regression analysis (Fig. 3). Both
albumin synthesis and plasma albumin concentration were posi-
tively correlated with IGF-1 levels (Fig. 4).
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evidence that the primary defect is a reduced rate of albumin
synthesis.
There was no relationship between external albumin loss,
nutritional parameters, or dialysis dose delivered and either
albumin synthesis or albumin concentration. An exception was the
negative relationship between albumin synthesis and Kt/Vurea, not
the positive relationship expected if underdialysis were the cause
of hypoalbuminemia. The difference in Kt/Vurea was entirely due
to differences in the Vurea term, since the same dialyzers were
used for all patients and treatment time was the same. There was
strong evidence for a relationship between acute-phase reactants
and both the rate of albumin synthesis and albumin concentration.
The cause of the acute-phase response in these patients was not
clinically evident. None had obvious shunt or access infections.
Although there was no statistical difference in dialysis reuse
between the two groups, the differences in reuse may have
contributed a biologically significant effect to albumin homeo-
stasis. While transmembrane albumin losses did not cause the
hypoalbuminemia, it is possible that the altered membrane may
have activated white cells or that mediators of inflammation may
have crossed the membrane and entered the patient's blood
stream. Against this latter proposal is the observation that none of
the patients suffered a febrile response while on dialysis and that
febrile reactions are unusual in our dialysis center [39]. Also, there
was no correlation between the reuse number and level of
acute-phase reactants in this study.
The hypoalbuminemic patients tended to be older than the
patients with a normal plasma albumin. Albumin synthesis has not
been found to change with age. To the contrary, albumin synthesis
is increased in the aged rat [40]. When compared to young adult
men, elderly men maintain a normal rate of albumin synthesis
even when placed on a protein restricted diet [41].
Several investigators have reported reduced plasma IGF-1
levels in patients judged to be malnourished by other criteria [42,
43], that is, anthropometric indices, hypoproteinemia, hypoalbu-
minemia, hypotransferrinemia and anemia, but indices of malnu-
trition were not found in our patients. Moller et al reported
reduced plasma IGF-1 levels in patients with burns that correlated
with the degree of injury [44]. In another study of burned patients,
IGF-1 levels decreased within 24 hours of severe injury and
increased during recovery, but the changes were unrelated to
nitrogen balance, suggesting that the inflammatory response may
have been responsible for the decreased IGF-1 levels [45].
Hakim et al reported that hemodialyzed patients who switched
from bio-incompatible membranes to biocompatible membranes
experienced an increase first in IGF-1 levels, and followed by
increases in albumin [46]. While they interpreted their data as
showing improved nutritional status in the patients dialyzed with
the biocompatible membrane, the changes could have been a
consequence of a reduced inflammatory reaction.
We found no evidence that nutritional intake differed between
these groups during the six weeks period of study. Koppel et al
proposed that dietary protein and calorie intake should be 1.2
g/kglday and 35 kCal!kg/day, respectively, in patients on hemodi-
alysis [47], a value greater than recommended for the rest of the
population and in excess of that received by either group of
patients in the present study. Although it is possible that increas-
ing both protein and calorie intake in the low albumin group
might have normalized albumin synthesis, albumin concentration
and IGE-i levels, nutritional supplementation either orally or
parenterally (IDPN) have proved ineffectual [14, 15, 48] or only
partially effective [49] in repairing hypoalbuminemia. Schulman et
al have shown an additive effect of recombinant human growth
hormone (rHGH) when used with IDPN in hemodialysis patients
[50] to improve nitrogen balance and plasma albumin. The
apparent inability of these patients to produce normal plasma
levels of IGF-1 despite adequate levels of endogenous growth
hormone and identical nutritional intake suggests that reduced
levels of IGF-1 may actually interfere with the anabolic responses
expected from adequate protein and calorie intake rather than
simply provide evidence of deprivation. We suggest that the
hypoalbuminemic patients have an inflammatory block to albumin
synthesis as a component of the acute-phase response that also
includes a decrease in IGF-1.
We do not propose that protein-calorie malnutrition is unim-
portant in the ESRD population as a whole. Ample evidence of
protein calorie malnutrition has been published to support that
hypothesis [10—12]. However, hypoalbuminemia persists even
when patients have been dialyzed according to current recommen-
dations using high efficiency modern dialyzers and after dietary
protein intake has been raised to acceptable levels. The cause of
inflammation must be elucidated to further resolve this problem.
These studies suggest that it may be unwise to continue to use the
terms hypoalbuminemia and malnutrition synonymously, since
assumptions contained in the malnutrition paradigm may obscure
other processes responsible for reduced albumin levels.
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